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Risk assessment of new sequencing data of  
GM maize event GA21 
EFSA Panel on Genetically Modified Organisms (GMO) 
Abstract 
In 2007, 2010 and 2011, the European Food Safety Authority (EFSA) Panel on Genetically Modified 
Organisms (GMO Panel) concluded the assessment of genetically modified (GM) maize GA21, 
MIR604  GA21 and MIR604  GA21  Bt11. These were found to be as safe as their conventional 
counterparts and other appropriate comparators with respect to potential effects on human and 
animal health and the environment. On 23 July 2015, the European Commission (EC) received from 
Syngenta new nucleic acid sequencing data on maize event GA21 and updated bioinformatic analyses 
using the new sequencing data. The EC tasked EFSA to analyse these data and to indicate whether 
the previous conclusions of the EFSA GMO Panel on the above-listed GM maizes remain valid. The 
EFSA GMO Panel used the appropriate principles described in its guidelines for the risk assessment of 
GM plants to analyse the received data. Compared with the sequencing data originally provided, the 
new sequencing data indicated a one-base pair addition in a non-coding region of the insert, a three-
base pair deletion in the 3’ flanking region of the insert, and a difference in the number of functional 
copies of the mepsps expression cassette. These differences were only recently identified, but it was 
confirmed that they had been present in the original plant material used for the risk assessment. 
Thus, with the exception of bioinformatics analyses, the studies performed for the risk assessment 
remain valid. The bioinformatic analyses performed on the new sequence did not give rise to safety 
issues. Therefore, the GMO Panel concludes that the original risk assessment of event GA21 as a 
single event, and as a part of stacked events, remains valid. 
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1. Introduction  
Genetically modified (GM) maize event GA21 was developed to confer tolerance to glyphosate (N-
(phosphonomethyl)glycine)-based herbicides. This is achieved by the production of the mEPSPS (5-
enolpyruvylshikimate-3-phosphate synthase) protein, which has a low binding affinity for glyphosate 
and maintains enzymatic activity in its presence. 
The EFSA GMO Panel has previously assessed maize GA21 as a single event and as part of stacked 
events (see Table 1).  
Table 1:  EFSA GMO Panel scientific opinions on maize event GA21 
Event Application EFSA Scientific Opinions 
GA21 EFSA-GMO-UK-2005-19 EFSA, 2007 
EFSA-GMO-RX-GA21 
EFSA-GMO-UK-2008-60 EFSA GMO Panel, 2011a 
Bt11  GA21 EFSA-GMO-UK-2007-48 EFSA GMO Panel, 2010a 
Bt11  MIR604  GA21 EFSA-GMO-UK-2008-56 EFSA GMO Panel, 2010b 
 Background and Terms of Reference as provided by the requestor 1.1.
On 23 July 2015, Syngenta sent to the European Commission (EC) new sequencing information 
relating to maize events MIR604 and GA21, on the basis of Articles 9 and 21 of Regulation (EC) 
1829/2003.  
On 7 August 2015, the EC requested EFSA to analyse the data and analyses provided by Syngenta 
and indicate whether the conclusions of adopted opinion for maizes MIR604 and GA21 as single 
events or as part of stacked events, have to be adapted. 
Subsequently, the EFSA GMO Panel evaluated the data and methodology provided for maize events 
MIR604 and GA21 and considered these elements in the context of previous conclusions.  
The two maize events mentioned in the EC request, MIR604 and GA21, are addressed in independent 
EFSA GMO Panel statements. This statement addresses the data on maize event GA21.1  
2. Methodologies and Data  
 Methodologies 2.1.
The applicant followed the EFSA GMO Panel guidelines for the risk assessment of GM plants (EFSA 
GMO Panel, 2011b) to investigate the insert sequence and to perform the bioinformatic analyses.  
In delivering this statement, the GMO Panel took into account the appropriate principles described in 
its guidelines for the risk assessment of GM plants (EFSA GMO Panel, 2011b). 
 Data 2.2.
In delivering this statement, the EFSA GMO Panel took into account information provided by the 
applicant. 
2.2.1. Sequence information previously submitted to EFSA for GA21 
The applicant had previously submitted information on the sequence of maize event GA21, as part of 
application EFSA-GMO-UK-2005-192; this information was updated in the context of application EFSA-
GMO-UK-2008-60.3 
                                                          
1 The EFSA GMO Panel statement on maize MIR604, is published in the EFSA Journal http://www.efsa.europa.eu/sites/default/
files/scientific_output/files/main_documents/4255.pdf  
2 Annex SSB-129-05 (confidential information). 
3 Annex SSB-129-05 A1 (confidential information). 
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Maize GA21 was reported to contain one insert that comprised three complete and three incomplete 
copies of the mepsps expression cassette,4 as follows: 
 Copy 1 contains an incomplete rice actin promoter, while the rest of the expression cassette is 
intact. 
 Copies 2, 3 and 4 are complete. 
 Copy 5 contains the rice actin promoter, first exon and intron, the optimised transit peptide 
and a fragment of the mepsps sequence; the nos terminator is lacking in this copy. 
 Copy 6 contains only the rice actin promoter and a truncated actin first exon. 
2.2.2. New sequence information for GA21 submitted as part of the current 
mandate 
The applicant has recently re-sequenced the GA21 event in a stacked product, which revealed three 
discrepancies relative to the GA21 insert sequence recorded and reported in 2005 (EFSA-GMO-UK-
2005-19). The differences are a nucleotide change in the actin promoter of copy 6, a three-base pair 
deletion within the 3’ insert flanking region, and a difference in the number of complete mepsps 
cassettes present within the insert (see Table 2).   
Table 2:  Identified discrepancies in the sequence of the insert and flanking regions in maize GA21 
Identified discrepancy Reported in 2005 Reported in 2015 
Actin promoter of copy 6 GTCGGATA GTCGGGATA 
3’ flanking region GCCGCCTTT GCC---ATT 
Expression cassette copy 
number 
3 complete and 3 truncated copies 2 complete and 3 truncated copies 
 
To further investigate the origin of these differences, genomic DNA from the same GA21 material 
analysed in 2005 (EFSA-GMO-UK-2005-19) was used to re-sequence the GA21 insert and flanking 
regions.5 The results indicated that the differences found in the stack were also present in the original 
GA21 material.  
The updated length and structure of the insert were also confirmed by Southern blot analyses, by 
using a combination of four enzymes with the mepsps-specific probe.  
The applicant carried out bioinformatic analyses using the updated nucleotide sequence in order to 
investigate (1) if any known maize genes were disrupted by the GA21 insert; (2) if the newly 
expressed protein or any other open reading frame (ORF) present within the insert and spanning the 
junction sites shows similarity to known allergens or toxins; and (3) if the flanking sequences and the 
insert contain sequences that would facilitate horizontal gene transfer to microorganisms. 
3. Assessment of the potential consequences of the new sequence 
information 
From the data provided by the applicant, it can be concluded that the sequence differences found in 
2015 were already present in the original material used in the risk assessment process (EFSA GMO 
Panel, 2007; EFSA GMO Panel 2010a, b, 2011a). The data also show that the structure of the insert 
did not change and that the original material used for the risk assessment already contained two 
complete copies of the expression cassette, and not three, as erroneously reported in 2005. 
The identified nucleotide sequence differences are located outside the coding sequence for the 
mEPSPS protein. Furthermore, the difference in the number of copies within the insert does not create 
                                                          
4 The mepsps expression cassette contains the following elements: the 5’ region of the actin 1 gene from rice, containing the 
promoter, first exon and intron; an optimised transit peptide constructed based on sequences from maize and sunflower 
ribulose-1,5-bisphosphate carboxylase oxygenase (RuBisCo) genes; a modified maize epsps gene; and the 3’ non-translated 
region from the nos gene from Agrobacterium tumefaciens.  
5 Additional information 11/09/2015. 
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new junction sequences. Therefore, with the exception of some aspects of the bioinformatic analyses, 
the studies performed for the risk assessment remain valid.  
Considering the location of the identified nucleotides differences (in the 3’ flanking region and in the 
actin promoter of copy 6), only the analysis of ORFs containing these differences with regard to 
potential similarity with allergens or toxins, as well as their implications on the potential for horizontal 
gene transfer, were considered relevant for the current assessment. 
The search for similarity to allergens was performed using the (FAO/WHO) criterion of 35 % identity 
in a window of 80 amino acids. Results indicate that none of the ORFs containing the identified 
differences show similarity with known allergens or toxins.  
Sequence analysis did not identify any similarity between the regions containing the identified 
differences and microbial sequences. Therefore, these differences do not affect the likelihood of HGT.  
4. Conclusions 
The EFSA GMO Panel was asked to evaluate the data provided by Syngenta for maize GA21 and to 
indicate whether its previous conclusions on this event remain valid. 
The original material used in the risk assessment process already contained the differences reported 
in 2015. The change in the number of copies of the expression cassette actually present within the 
insert does not give rise to safety concerns. The nucleotide sequence differences are located outside 
the coding region of the insert and the bioinformatic analyses performed on the new sequence did not 
give rise to safety concerns. Therefore, the GMO Panel concludes that the original risk assessment of 
event GA21 as a single event, and as a part of stacked events, remains valid. 
Documentation provided to EFSA  
1. Letter from the European Commission, received on 7 August 2015, concerning a request to 
analyse new sequencing information of maize events MIR604 and GA21. 
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